Thu, February 22, 2018

Geoff Meacham Maintained (UTHR) at Sell with Decreased Target to $105 on, Feb 22nd, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-105-on-feb-22nd-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Geoff Meacham of Barclays, Maintained "United Therapeutics Corporation" (UTHR) at Sell with Decreased Target from $115 to $105 on, Feb 22nd, 2018.

Geoff, nor any peers, have made any analyst calls on UTHR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30